Smartlens, Inc. Closes $6.1M Series A Led By Ambit Health Ventures With Investments From Prominent Institutions And Stanford University
Amount Raised
$6.1 Million
Round Type
Series A
Mountain ViewManufacturingInformation TechnologyBiotechnologyHealth CareTherapeuticsInvestors
Description
Smartlens, Inc., a clinical-stage ophthalmic technology company, has closed an oversubscribed $6.1M Series A equity financing round to advance regulatory clearance for miLens, a novel, electronics-free, soft contact lens for monitoring diurnal intraocular pressure (IOP).
Quick answer
Smartlens raised $6.1 Million in a Series A round, dated July 11, 2023. Investors: Boutique Venture Partners, 3 E Bioventures, Smartlens, Stanford University, Graphene Ventures, Sophia Innovation Capital, Plaisance Capital Management and Wilson Sonsini Investments. Smartlens is based in Mountain View, California, United States.
- How much did Smartlens raise?
- Smartlens raised $6.1 Million in a Series A round on July 11, 2023.
- Who invested in Smartlens?
- Boutique Venture Partners, 3 E Bioventures, Smartlens, Stanford University, Graphene Ventures, Sophia Innovation Capital, Plaisance Capital Management and Wilson Sonsini Investments are named as investors in this round.
- What does Smartlens do?
- Smartlens is developing novel solutions for managing glaucoma and other anterior segment eye diseases.
- Where is Smartlens based and how big is it?
- Smartlens is based in Mountain View, California, United States. Fundz records about 14 employees.
- Who are the decision-makers at Smartlens?
- Fundz holds 1 contact at Smartlens. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Manufacturing around the same time
Companies in the same sectors as Smartlens that raised within 45 days of this round, from Fundz verified event records.
- Nature's Toolbox raised $10M on August 25, 2023.
- Fore Biotherapeutics raised $75M (Series D) on August 24, 2023.
- Rapport raised $150M (Series B) on August 24, 2023.
- Advanced NanoTherapies raised $4M (Seed) on August 22, 2023.
- Actimed Therapeutics raised $6.1M (Series A) on August 22, 2023.
- Abcuro raised $155M (Series B) on August 17, 2023.
Who to call at Smartlens, and when
A new round usually means Smartlens is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Smartlens raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Smartlens, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Smartlens. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Smartlens raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSmartlens raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.